1. Home
  2. SMLR vs CMPS Comparison

SMLR vs CMPS Comparison

Compare SMLR & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMLR
  • CMPS
  • Stock Information
  • Founded
  • SMLR 2007
  • CMPS 2020
  • Country
  • SMLR United States
  • CMPS United Kingdom
  • Employees
  • SMLR N/A
  • CMPS N/A
  • Industry
  • SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CMPS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMLR Health Care
  • CMPS Health Care
  • Exchange
  • SMLR Nasdaq
  • CMPS Nasdaq
  • Market Cap
  • SMLR 289.5M
  • CMPS 280.2M
  • IPO Year
  • SMLR 2014
  • CMPS 2020
  • Fundamental
  • Price
  • SMLR $71.84
  • CMPS $4.41
  • Analyst Decision
  • SMLR
  • CMPS Strong Buy
  • Analyst Count
  • SMLR 0
  • CMPS 7
  • Target Price
  • SMLR N/A
  • CMPS $30.67
  • AVG Volume (30 Days)
  • SMLR 1.1M
  • CMPS 842.0K
  • Earning Date
  • SMLR 11-04-2024
  • CMPS 10-31-2024
  • Dividend Yield
  • SMLR N/A
  • CMPS N/A
  • EPS Growth
  • SMLR N/A
  • CMPS N/A
  • EPS
  • SMLR 2.04
  • CMPS N/A
  • Revenue
  • SMLR $58,938,000.00
  • CMPS N/A
  • Revenue This Year
  • SMLR N/A
  • CMPS N/A
  • Revenue Next Year
  • SMLR N/A
  • CMPS N/A
  • P/E Ratio
  • SMLR $31.66
  • CMPS N/A
  • Revenue Growth
  • SMLR N/A
  • CMPS N/A
  • 52 Week Low
  • SMLR $20.88
  • CMPS $4.00
  • 52 Week High
  • SMLR $79.45
  • CMPS $12.75
  • Technical
  • Relative Strength Index (RSI)
  • SMLR 67.75
  • CMPS 41.38
  • Support Level
  • SMLR $58.75
  • CMPS $4.00
  • Resistance Level
  • SMLR $65.97
  • CMPS $4.91
  • Average True Range (ATR)
  • SMLR 7.71
  • CMPS 0.26
  • MACD
  • SMLR -0.05
  • CMPS 0.06
  • Stochastic Oscillator
  • SMLR 72.28
  • CMPS 45.05

About SMLR Semler Scientific Inc.

Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Share on Social Networks: